Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

677
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
677
Amino Acid Biosynthetic Pathways01:29

Amino Acid Biosynthetic Pathways

977
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
977
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

7.4K
The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
7.4K
Bone Disorders01:29

Bone Disorders

5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

4.9K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
4.9K
Introduction to Metabolism01:30

Introduction to Metabolism

2.5K
Metabolism encompasses all biochemical reactions in a living organism, facilitating both the breakdown and synthesis of biomolecules. These metabolic processes are categorized into catabolic and anabolic pathways, which operate in a coordinated manner to ensure energy balance and cellular function.Catabolic Pathways and Energy ReleaseCatabolic pathways involve the breakdown of complex macromolecules such as carbohydrates, lipids, and proteins into smaller structures like monosaccharides, fatty...
2.5K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Polypharmacologic phosphoinositide modulation by FTY720 triggers endomembrane trafficking collapse and metabolic starvation in cancer cells.

Biochemical and biophysical research communications·2026
Same author

14-3-3ζ interacts with DNA-binding domain of FOXO3a and competitively dissociates DNA by dual-motif tethering.

Nature communications·2026
Same author

Application of differential scanning fluorimetry to X-ray protein crystallography.

IUCrJ·2026
Same author

misteINK: a protein nanocage-based ink with reversible, stimuli-responsive color shifts.

Biomaterials science·2025
Same author

IMPDH and GTP Metabolism in Cancer: Mechanisms, Regulation, and Translational Scope.

Cancer science·2025
Same author

Synthesis of new vitamin K derivatives with a ketone group at the C-1' position of the side chain and their conversion to menaquinone-4.

Journal of molecular structure·2025

Video Experimental Relacionado

Updated: Jan 7, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

5.0K

Una nueva vía metabólica en el raquitismo tipo 3

Toshiya Senda1, Yoshihisa Hirota2

  • 1Structural Biology Research Center, Institute of Materials Structure Science, High Energy Accelerator Research Organization (KEK), Tsukuba, Japan.

The FEBS journal
|December 30, 2025
PubMed
Resumen

El raquitismo tipo 3, recientemente identificado, implica una mutación de ganancia de función en el gen CYP3A4, lo que lleva a un metabolito inactivo de la vitamina D y a niveles insuficientes de vitamina D activa. Este descubrimiento ofrece una nueva dirección de investigación para el raquitismo.

Palabras clave:
11α,25‐dihidroxivitamina D3 [11α,25(OH)2D3]CYP3A4(I301T)citocromo P450raquitismo dependientemutación de ganancia de funciónraquitismo tipo 3vitamina Dinactivación/hidroxilación C-11 de la vitamina D

Más Videos Relacionados

Using Real-Time Cell Metabolic Flux Analyzer to Monitor Osteoblast Bioenergetics
09:43

Using Real-Time Cell Metabolic Flux Analyzer to Monitor Osteoblast Bioenergetics

Published on: March 1, 2022

3.7K
Assessing Energy Substrate Oxidation In Vitro with 14CO2 Trapping
09:20

Assessing Energy Substrate Oxidation In Vitro with 14CO2 Trapping

Published on: March 23, 2022

2.4K

Videos de Experimentos Relacionados

Last Updated: Jan 7, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

5.0K
Using Real-Time Cell Metabolic Flux Analyzer to Monitor Osteoblast Bioenergetics
09:43

Using Real-Time Cell Metabolic Flux Analyzer to Monitor Osteoblast Bioenergetics

Published on: March 1, 2022

3.7K
Assessing Energy Substrate Oxidation In Vitro with 14CO2 Trapping
09:20

Assessing Energy Substrate Oxidation In Vitro with 14CO2 Trapping

Published on: March 23, 2022

2.4K

Área de la Ciencia:

  • Bioquímica
  • Genética
  • Endocrinología

Sus antecedentes:

  • El raquitismo, un trastorno óseo, se relacionó históricamente con la deficiencia de vitamina D.
  • Las mutaciones genéticas que afectan la activación de la vitamina D o el metabolismo mineral causan diversas formas de raquitismo.
  • Investigaciones recientes identificaron una nueva causa genética de raquitismo.

Objetivo del estudio:

  • Describir una forma genética de raquitismo recién identificada.
  • Elucidar el mecanismo molecular detrás de este nuevo tipo de raquitismo.
  • Introducir una novedosa mutación de ganancia de función en el gen CYP3A4 como causa de raquitismo.

Principales métodos:

  • Secuenciación genética para identificar mutaciones.
  • Ensayos de actividad enzimática para estudiar el metabolismo de la vitamina D.
  • Análisis de metabolitos para identificar productos de la vitamina D.

Principales resultados:

  • Se identificó una mutación de ganancia de función (Ile301Thr) en el gen CYP3A4 como la causa del raquitismo tipo 3.
  • La enzima CYP3A4 mutante produce un metabolito inactivo de la vitamina D, el 11α,25(OH)2D3.
  • Esto resulta en una deficiencia de la forma activa de la vitamina D.

Conclusiones:

  • El raquitismo tipo 3 es causado por una mutación única de ganancia de función en el gen CYP3A4.
  • El descubrimiento de este mecanismo y metabolito proporciona nuevas perspectivas sobre el raquitismo.
  • Este hallazgo abre nuevas vías para la investigación del raquitismo y las posibles estrategias terapéuticas.